Mota-T Ciwon ƙwayar cuta, CAR T Therapy, T-Cell CAR, wakili na chimeric
Zurfafa Zurfi cikin CAR T Cell Therapy: Yaya Aiki yake?
Gano kimiyyar da ke bayan CAR T Cell therapy magani a Indiya! Bincika yadda wannan maganin juyin juya hali ke canza ƙwayoyin garkuwar jikin ku zuwa mayaƙan ciwon daji. Karanta blog ɗinmu yanzu don ƙarin koyo game da wannan maganin ban mamaki da yadda ..
T-Cell CAR, CAR far, immunotherapy, T cell far
Shin CAR T-Cell Ana Samun Farfawar Kwayoyin cuta A Indiya?
Shin kun taɓa tunanin ko akwai wata hanya mai ƙarfi don yaƙi da cutar kansa? Yanzu kawai ka yi tunanin idan wata rana ka sami haske na bege a cikin yaƙin da kake yi da kansa, maganin da ke amfani da ƙarfin garkuwar jikinka don kai hari.
Mota-T Ciwon ƙwayar cuta, T-Cell CAR, Mai karɓar Agent Chimeric, Korea, Seoul, Koriya ta Kudu
Kamfanoni a Koriya sun ɗauki mataki kusa da haɓaka haɓakar CAR T-Cell na gida
Mayu 2023: Chimeric antigen receptor (CAR) T-cell far wani sabon ci gaba ne a fagen maganin kansar mutum. Nasu T-cells na majiyyaci ana gyaggyarawa ta kwayoyin halitta yayin aikin kera don bayyana wani.
fasahar binciken halittu, Mota-T Ciwon ƙwayar cuta, T-Cell CAR, CAR far, Sin, tara kudi, Oricell Therapeutics
Oricell yana haɓaka ƙarin $45M USD don faɗaɗa maganin CAR T-Cell zuwa Amurka
23 ga Maris, 2023: Na'urar rigakafin ciwon daji da farkon matakin da Shanghai Biotech Oricell ke samarwa sun sami ƙarin dala miliyan 45 a cikin tallafi, kamfanin ya sanar a ranar Talata. Bayan an nuna shi a AS..
BRL Biotech, T-Cell CAR, CARsgen Therapeutics, China CAR T Cell, IASO Biotherapeutics, Juventas Therapeutics, Relma-cel
Ta yaya kasar Sin ke jagorantar ci gaban CAR T-Cell far?
Maris 2023: CAR-T-cell far sabon labari ne kuma ingantaccen tsarin maganin cutar kansa wanda ya kawo sauyi kan maganin cutar kansa, musamman kansar jini. Wannan maganin yana samun sakamako na warkewa ko yana warkar da cuta ta hanyar gyara.
Mota-T Ciwon ƙwayar cuta, T-Cell CAR, Emily Littlejohn, immunology, lupus farfadowa
Sabuwar maganin CAR T-Cell a cikin farfadowa na Lupus
Feb 2024: Several new drugs and promising therapies, such as chimeric antigen receptor T-cell therapy, have ushered in a "renaissance" for lupus, according to a speaker at the symposium Basic and Clinical Immunology for the Busy ..
ƙwayoyin mota, CAR T Therapy, T-Cell CAR, Immunotherapy magani
Za a iya rage lokacin kera CAR T-Cell zuwa kwana ɗaya?
Afrilu 2022: A al'ada, tsarin kera tantanin halitta don CAR T-cell far yana ɗaukar kwanaki tara zuwa sha huɗu; duk da haka, masu bincike a Jami'ar Pennsylvania sun sami damar ƙirƙirar ƙwayoyin CAR T masu aiki tare da ingantattun ƙwayoyin cuta.
Mota-T Ciwon ƙwayar cuta, Mota T, CAR T Cell far in China, T-Cell CAR, Sin, Jiyya a China
Cibiyar CAR-T ta kasar Sin ta sami nasarar samun sakamako na gwaji na asibiti
June 2016: Professor Huang He of Zhejiang University's First Affiliated Hospital presented the outcomes of 10 clinical cases, including CAR-T cell therapy for leukaemia treatment, at the 2016 Haematogenic Immunity Summit in Hangz..
BMS, Breyanzi, Mota-T Ciwon ƙwayar cuta, T-Cell CAR, CART far, USFDA
Breyanzi - Sabon C-T-Cell far daga BMS
Yuli 2021: Breyanzi (Lisocabtagene maraleucel; liso-cel), wani labari CD19-directed chimeric antigen receptor (CAR) T cell magani wanda Bristol Myers Squibb (BMS) ya haɓaka, Hukumar Abinci da Magunguna ta Amurka (US.
Mota T, T-Cell CAR, Cell far, Egfr, Saukewa: EGFR806, GPC3, Kwayoyin PC-T, Rana Yat-sen, Farashin TGF
CAR T-Cell farfadowa da yarda
Yuli 2021: A watan Yuni 2014, Kamfanin KITE Biotechnology, mai ma'aikata 19 kawai, an jera shi akan NASDAQ a Amurka, kuma ya ɗauki dalar Amurka miliyan 130 a rana ɗaya! Bayan watanni biyu kacal, Juno Biotechnology yana da ƙasa da 20 em.